| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/04/2011 | CA2467828C Pharmaceutical formulations comprising an immune response modifier |
| 10/04/2011 | CA2452871C Oxymorphone controlled release formulations |
| 10/04/2011 | CA2391898C Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 10/04/2011 | CA2346330C Medicated chewing gum delivery system for nicotine |
| 09/30/2011 | CA2735634A1 Patch preparation and production method thereof |
| 09/30/2011 | CA2735598A1 Film-form preparation and method for producing the same |
| 09/30/2011 | CA2735592A1 Film-form preparation and method for producing the same |
| 09/30/2011 | CA2735513A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation |
| 09/29/2011 | WO2011120033A1 Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
| 09/29/2011 | WO2011120001A1 Oral ph and buffering capacity modifiers |
| 09/29/2011 | WO2011119995A2 Formulations and methods of use |
| 09/29/2011 | WO2011119988A1 Methods of treatment of hepatocellular carcinoma |
| 09/29/2011 | WO2011119929A2 Composition for enhancing athletic performance |
| 09/29/2011 | WO2011119903A2 Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers |
| 09/29/2011 | WO2011119881A1 Multi-compartmental macrophage delivery |
| 09/29/2011 | WO2011119839A1 Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
| 09/29/2011 | WO2011119588A1 Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| 09/29/2011 | WO2011119585A2 Aerosol foams comprising clindamycin phosphate |
| 09/29/2011 | WO2011119477A2 Pharmaceutical compositions of carvedilol salts and process for preparation thereof |
| 09/29/2011 | WO2011119288A2 Multilayer melt-extruded film |
| 09/29/2011 | WO2011119287A1 Melt-extruded film |
| 09/29/2011 | WO2011119262A1 Methods and systems for generating nanoparticles |
| 09/29/2011 | WO2011119247A2 Topical skincare composition |
| 09/29/2011 | WO2011119228A1 Nanoemulsion including sucrose fatty acid ester |
| 09/29/2011 | WO2011119126A1 Use of oxalic acid in the production of a therapeutic preparation with anti-tumour activity in relation to malignant cells, a therapeutic preparation based thereon and a method of treatment |
| 09/29/2011 | WO2011119125A1 Use of lithium oxalate in production of a therapeutic preparation with anti-tumour activity in relation to malignant cells, a therapeutic preparation based thereon and a method of treatment |
| 09/29/2011 | WO2011119059A1 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof |
| 09/29/2011 | WO2011119058A2 F3-peptide targeted lipid-based nanoparticles useful for the treatment of angiogenesis-dependent diseases |
| 09/29/2011 | WO2011118960A2 Method for preparing nano-particles |
| 09/29/2011 | WO2011118958A2 Oil-in-water type nano-emulsion composition and method for preparing same |
| 09/29/2011 | WO2011118810A1 Nutritional composition |
| 09/29/2011 | WO2011118683A1 Patch for medical use |
| 09/29/2011 | WO2011118604A1 Hydrous adhesive patch |
| 09/29/2011 | WO2011118454A1 Solid preparation |
| 09/29/2011 | WO2011118453A1 Solid preparation |
| 09/29/2011 | WO2011117884A1 Stable pharmaceutical compositions comprising fesoterodine |
| 09/29/2011 | WO2011117883A1 Pharmaceutical composition of mycophenolate mofetil and process for preparing thereof |
| 09/29/2011 | WO2011117851A1 Transdermal administration of peptides |
| 09/29/2011 | WO2011117391A2 Novel composition for treatment of essential thrombocythemia |
| 09/29/2011 | WO2011117389A1 Antimicrobial oil-in-water emulsion |
| 09/29/2011 | WO2011117384A1 Antimicrobial wound dressing |
| 09/29/2011 | WO2011117378A2 Improved methods and compositions for safe and effective treatment of telangiectasia |
| 09/29/2011 | WO2011117377A2 Improved methods and compositions for safe and effective treatment of erythema |
| 09/29/2011 | WO2011117362A1 Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells |
| 09/29/2011 | WO2011117313A1 Fast dissolving drug delivery systems |
| 09/29/2011 | WO2011117306A1 Double-layer pharmaceutical formulations containing opioid agonists and antagonists |
| 09/29/2011 | WO2011116973A1 Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe |
| 09/29/2011 | WO2011116962A1 Process of treatment of fibers and/or textile materials |
| 09/29/2011 | WO2011116738A2 Novel support system for the transport of active substances into the skin |
| 09/29/2011 | WO2011095314A3 Preparation of a powdery pharmaceutical composition by means of an extruder |
| 09/29/2011 | WO2011092708A3 Liposomes comprising amphipathic drugs and method for their preparation |
| 09/29/2011 | WO2011062936A3 Self-assembled toroidal-spiral particles and manufacture and uses thereof |
| 09/29/2011 | WO2011061498A3 Inhalation solutions |
| 09/29/2011 | WO2011057266A3 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing |
| 09/29/2011 | WO2011056793A3 Composition, method, and kit for alpha-1 proteinase inhibitor |
| 09/29/2011 | WO2011056785A3 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| 09/29/2011 | WO2011035343A3 Phentermine liquid dosage form |
| 09/29/2011 | WO2011031301A3 Intrapericardial delivery of periostin |
| 09/29/2011 | WO2011026125A3 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 09/29/2011 | WO2010143972A3 Acoustically sensitive drug delivery particles comprising inverted structure forming lipids |
| 09/29/2011 | WO2010143969A3 Acoustically sensitive drug delivery particles comprising phosphatidylethanolamine |
| 09/29/2011 | WO2010138539A3 Reduction of flake-like aggregation in nanoparticulate active agent compositions |
| 09/29/2011 | WO2010106063A3 Composite materials loaded with therapeutic and diagnostic agents comprising polymer nanoparticles and polymer fibers |
| 09/29/2011 | WO2010103116A3 Method of treating eczema |
| 09/29/2011 | WO2010097217A3 Sugar-coating product for sugar-coating medicaments and food |
| 09/29/2011 | WO2010017265A3 Injectable extended release compositions containing an ion channel blocker for the treatment of arthritis |
| 09/29/2011 | US20110238186 Preparation of regenerative tissue scaffolds |
| 09/29/2011 | US20110238036 Sustained release delivery devices |
| 09/29/2011 | US20110238021 Transdermal delivery device and method |
| 09/29/2011 | US20110238016 Drug delivery to a joint |
| 09/29/2011 | US20110238003 Method for systemic drug delivery through the nail |
| 09/29/2011 | US20110237862 MULTIFUNCTIONAL Fe3O4 CORED MAGNETIC-QUANTUM DOT FLUORESCENT NANOCOMPOSITES FOR RF NANO-HYPERTHERMIA OF CANCER CELLS |
| 09/29/2011 | US20110237858 Device and Methods for Sequential, Regional Delivery of Multiple Cytotoxic Agents and Directed Assembly of Wound Repair Tissues |
| 09/29/2011 | US20110237811 Stabilized steroid composition and method for its preparation |
| 09/29/2011 | US20110237747 Multi-Arm Polypeptide-Poly(ethylene glycol) Block Copolymers as Drug Delivery Vehicles |
| 09/29/2011 | US20110237710 Aqueous dispersions of at least one biodegradable polymer |
| 09/29/2011 | US20110237681 Inhalable epinephrine |
| 09/29/2011 | US20110237504 Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 09/29/2011 | US20110237435 Lipophilic nucleic acid delivery vehicle and methods of use thereof |
| 09/29/2011 | US20110236951 Biocomposite materials and methods for making the same |
| 09/29/2011 | US20110236685 Therapeutic calcium phosphate particles and methods of manufacture and use |
| 09/29/2011 | US20110236562 Film preparation and process for preparing the same |
| 09/29/2011 | US20110236498 Suspensions Of Silicate Shell Microcapsules For Temperature Controlled Release |
| 09/29/2011 | US20110236497 Compositions and Methods for Improved Retention of a Pharmaceutical Composition at a Local Administration Site |
| 09/29/2011 | US20110236496 Emulsions for Microencapsulation Comprising Biodegradable Surface-Active Block Copolymers as Stabilizers |
| 09/29/2011 | US20110236495 Anti-cancer nanoparticle compositions and methods of use |
| 09/29/2011 | US20110236494 Ciprofloxacin oral suspension |
| 09/29/2011 | US20110236493 Porous materials |
| 09/29/2011 | US20110236492 Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives |
| 09/29/2011 | US20110236491 Topical anti-inflammatory composition |
| 09/29/2011 | US20110236490 Treatment or prevention of viral infection by chlorination |
| 09/29/2011 | US20110236489 Vaccine adjuvant combinations |
| 09/29/2011 | US20110236488 Herbal formulation for prevention and treatment of diabetes and associated complications |
| 09/29/2011 | US20110236487 Solid ganaxolone formulations and methods for the making and use thereof |
| 09/29/2011 | US20110236486 Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof |
| 09/29/2011 | US20110236485 Shell and core dosage form approaching zero-order drug release |
| 09/29/2011 | US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens |
| 09/29/2011 | US20110236483 Rna vector therapy |
| 09/29/2011 | US20110236482 Composition For The Prevention And Treatment Of Viral Infections |
| 09/29/2011 | US20110236481 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity |